The MarketReader Minute
๐ VCYT Soars on Earnings Beat, HALO and ZLAB Shine, ACAD Plummets on Downgrades, EXEL and MNKD Impress | Biotech Sector Insights
BeiGene Ltd reported strong Q2 2024 GAAP earnings per share, surpassing estimates, and its sales exceeded expectations, contributing positively to the ETF's performance. Additionally, Illumina's Q2 earnings, while missing estimates, showed a year-over-year increase and revenue.